Renovacor RCOR Stock
Renovacor Price Chart
Renovacor RCOR Financial and Trading Overview
| Renovacor stock price | 3.2 USD |
| Previous Close | 3.05 USD |
| Open | 3.04 USD |
| Bid | 0 USD x 1400 |
| Ask | 3.2 USD x 800 |
| Day's Range | 2.94 - 3.2 USD |
| 52 Week Range | 1.34 - 9.01 USD |
| Volume | 14.31K USD |
| Avg. Volume | 80.7K USD |
| Market Cap | 55.26M USD |
| Beta (5Y Monthly) | -0.330714 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.45 USD |
RCOR Valuation Measures
| Enterprise Value | -1060284 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.5384616 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2563801 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.03 |
Trading Information
Renovacor Stock Price History
| Beta (5Y Monthly) | -0.330714 |
| 52-Week Change | -62.48% |
| S&P500 52-Week Change | -8.00077% |
| 52 Week High | 9.01 USD |
| 52 Week Low | 1.34 USD |
| 50-Day Moving Average | 2.76 USD |
| 200-Day Moving Average | 2.78 USD |
RCOR Share Statistics
| Avg. Volume (3 month) | 80.7K USD |
| Avg. Daily Volume (10-Days) | 29.65K USD |
| Shares Outstanding | 17.27M |
| Float | 7.36M |
| Short Ratio | 1.51 |
| % Held by Insiders | 36.80% |
| % Held by Institutions | 52.66% |
| Shares Short | 52.19K |
| Short % of Float | 0.42% |
| Short % of Shares Outstanding | 0.29% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.79% |
| Return on Equity (ttm) | -27.44% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -35847000 USD |
| Net Income Avi to Common (ttm) | -13189000 USD |
| Diluted EPS (ttm) | -0.474 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 53.71M USD |
| Total Cash Per Share (mrq) | 3.2 USD |
| Total Debt (mrq) | 1.51M USD |
| Total Debt/Equity (mrq) | 3.53 USD |
| Current Ratio (mrq) | 6.6 |
| Book Value Per Share (mrq) | 2.547 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -29979000 USD |
| Levered Free Cash Flow (ttm) | -17038250 USD |
Profile of Renovacor
| Country | United States |
| State | CT |
| City | Greenwich |
| Address | P.O. Box 8142 |
| ZIP | 06836 |
| Phone | 610 424 2650 |
| Website | https://www.renovacor.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
Q&A For Renovacor Stock
What is a current RCOR stock price?
Renovacor RCOR stock price today per share is 3.2 USD.
How to purchase Renovacor stock?
You can buy RCOR shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Renovacor?
The stock symbol or ticker of Renovacor is RCOR.
Which industry does the Renovacor company belong to?
The Renovacor industry is Biotechnology.
How many shares does Renovacor have in circulation?
The max supply of Renovacor shares is 17.27M.
What is Renovacor Price to Earnings Ratio (PE Ratio)?
Renovacor PE Ratio is 0.00000000 now.
What was Renovacor earnings per share over the trailing 12 months (TTM)?
Renovacor EPS is 0 USD over the trailing 12 months.
Which sector does the Renovacor company belong to?
The Renovacor sector is Healthcare.